12 months(N = 139) | 24 months(N = 139) | |
---|---|---|
*Includes one patient lost to follow up. | ||
†Includes patients with missing information. | ||
‡Percentages are based on the total number of patients with sufficient observation time at the given time point. | ||
Dead | 4 (2.9%)* | 13 (9.4%)* |
Alive | 135 (97.1%) | 103 (74.1%) |
Insufficient observation | – | 23 (16.5%) |
Patients with sufficient observation time‡ | (n = 139) | (n = 116) |
Bosentan alone | 121 (87%) | 87 (75%) |
Bosentan + other treatment | 7 (5%) | 8 (7%) |
Other or no treatment | 7 (5%)† | 8 (7%)† |
Dead | 4 (3%)* | 13 (11%)* |